MedinCell successfully renegotiates the drawdown conditions of the last tranche of the EIB loan and secures an additional €5m of non-dilutive funding June 10, 2020 June 10, 2020
MedinCell announces fiscal year consolidated results April 2019 – March 2020 June 4, 2020 June 4, 2020
Videoconference and publication of the results for the 2019-2020 financial year, on June 4, 2020 May 25, 2020 May 25, 2020
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle May 18, 2020 May 18, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis April 20, 2020 April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin April 6, 2020 April 6, 2020
BEPO®: Bioresorbable diblock mPEG-PDLLA and triblock PDLLA-PEG- PDLLA based in situ forming depots with flexible drug delivery kinetics modulation March 10, 2020 March 10, 2020
